Cancer Vaccines Market for Dendritic Cells Cancer Vaccines Segment to Grow at Fastest CAGR during Forecast Period
According to our new market research study on “Cancer Vaccines Market to 2027 – Asia Pacific Analysis and Forecast – by Technology, Type, Indication, and End Use,” the market is expected to reach US$ 3,131.09 million in 2027 from US$ 861.55 million in 2019; it is estimated to grow at a CAGR of 17.9% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific Cancer Vaccines Market and the drivers and restraints pertaining to the market growth.
Based on technology, the Cancer Vaccines market is segmented into in dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, viral vector cancer vaccines. The in recombinant cancer vaccines segment held the largest share of the market in 2019. Moreover, recombinant cancer vaccines is estimated grow at the highest CAGR in the market during the forecast period.
The Asia Pacific Cancer Vaccines market growth is mainly attributed to factors such as growing prevalence of cancer, and rising government initiatives to prevent it. However, the challenges in cancer vaccines industry like expensive cost restrains the growth of the market.
AstraZeneca, GlaxoSmithKline plc., Aduro Biotech Inc, Pfizer Inc., Sanofi, Bristol-Myers Squibb, Moderna, Inc., OncBioMune Pharmaceuticals Inc., MaxiVAX, Nouscom are among the leading companies operating in the Cancer Vaccines Market.
Asia Pacific Cancer Vaccines market, By Country, 2019(%share) Asia Pacific Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector Cancer Vaccines); Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); Indication (Cervical Cancer, Prostate Cancer, Other Indications); End User (Pediatrics, Adults), and Country and Geography
Asia Pacific Cancer Vaccines Market to Grow at a CAGR of 17.9% to reach US$ 3,131.09 Million from 2020 to 2027
Download Free Sample
The report segments Asia Pacific Cancer Vaccines market as follows:
By Technology
- Dendritic Cells Cancer Vaccines
- Recombinant Cancer Vaccines
- Antigen Cancer Vaccines
- Whole Cell Cancer Vaccines
- Viral Vector Cancer Vaccines
By Type
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccine
By Indication
- Cervical Cancer
- Prostate Cancer
- Other Indications
By End-Use
- Pediatrics
- Adults
By Country
- Japan
- China
- India
- Australia
- South Korea
- Rest of APAC
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com